The incorporation of [32p]p1 into phosphatidylinositol by rat fat-cells was markedly increased in the presence of adrenaline. Phosphatidic acid labelling was also increased, but to a lesser extent. These effects are due to a -adrenergic stimulation since they were unaffected by propranolol, blocked by a -blockers in the potency order prazosin < phentolamine < yohimbine and mimicked by methoxamine. The a-adrenergic stimulation of phosphatidylinositol labelling did not require extracellular Ca2 , which supports the hypothesis that an increased turnover of phosphatidylinositol is involved in a-adrenergic activation of Ca2+ entry. Insulin and the ionophore A23187 gave a small increase in 32p labelling of phosphatidylinositol in Ca2+-free medium containing 1mM-EGTA. The increases due to insulin or ionophore A23187 were abolished if 2.5 mM-Ca2+ was added to medium containing EGTA. However, the increases in labelling of phosphatidylinositol due to a-adrenergic amines were still evident in medium containing EGTA and Ca2+. Lipolytic agents such as corticotropin, dibutyryl cyclic AMP, adrenaline in the presence of phentolamine and isoproterenol decreased
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The incorporation of [32p] p1 into phosphatidylinositol by rat fat-cells was markedly increased in the presence of adrenaline. Phosphatidic acid labelling was also increased, but to a lesser extent. These effects are due to a -adrenergic stimulation since they were unaffected by propranolol, blocked by a -blockers in the potency order prazosin < phentolamine < yohimbine and mimicked by methoxamine. The a-adrenergic stimulation of phosphatidylinositol labelling did not require extracellular Ca2 , which supports the hypothesis that an increased turnover of phosphatidylinositol is involved in a-adrenergic activation of Ca2+ entry. Insulin and the ionophore A23187 gave a small increase in 32p labelling of phosphatidylinositol in Ca2+-free medium containing 1mM-EGTA. The increases due to insulin or ionophore A23187 were abolished if 2.5 mM-Ca2+ was added to medium containing EGTA. However, the increases in labelling of phosphatidylinositol due to a-adrenergic amines were still evident in medium containing EGTA and Ca2+. Lipolytic agents such as corticotropin, dibutyryl cyclic AMP, adrenaline in the presence of phentolamine and isoproterenol decreased
[32p]p1 incorporation into phosphatidylinositol, phosphatidylethanolamine and phosphatidic acid. This inhibitory effect may be secondary to accumulation of intracellular unesterified fatty acids, since it was decreased by incubating fewer cells in medium with 6 rather than 3% albumin and was restored by the addition of oleate to the medium. The incorporation of [ 32p1p1 into phosphatidylcholine was unaffected by lipolytic agents. The data suggest that there is an inhibition of the synthesis of certain phospholipids in the presence of lipolytic agents, which may be secondary to intracellular accumulation of unesterified fatty acids.
In adipocytes ,B-adrenergic stimulators activate adenylate cyclase and lipolysis. The role of cyclic AMP as a second messenger for fl-adrenergic stimulation is well established (Fain, 1979) . Much less is known about a-adrenergic effects. There is little effect of a-adrenergic activati;n on glucose oxidation, cyclic AMP accumulation and lipolysis in rat fat-cells (Fain, 1979) . However, Lawrence & Larner (1978) reported that activation of rat adipocyte phosphorylase and inactivation of glycogen synthase are produced by stimulation of aadrenergic receptors. The inactivation of glycogen synthase by a-adrenergic catecholamines was dependent on the presence of extracellular Ca2+ and may be secondary to increased entry of Ca2+ (Lawrence & Larner, 1978) .
Ca2+ has been postulated as a second messenger for a-adrenergic stimulation (Fain, 1979) and has also been implicated in insulin action (Fraser, 1975) . Vol. 186 In addition, an a-adrenergic stimulation of 42K+ efflux from rat adipocytes has been seen, which may be secondary to an increase in cytosol Ca2+ (Perry & Hales, 1970) . The mechanism by which aadrenergic agents increase influx of extracellular Ca2+ is not known. Activation of a-adrenergic and muscarinic receptors is generally accompanied by increased incorporation of [32p]p1 into phosphatidylinositol and it has been suggested that phosphatidylinositol turnover may be involved in the mobilization of Ca2+ (Michell, 1975 (Michell, , 1979 Jones & Michell, 1978) . Stein & Hales (1972) reported that in rat fat-cells, adrenaline stimulates the incorporation of ["2pIp1 into phosphatidylcholine and that incubation of fatcells with propranolol and adrenaline decreased the formation of phosphatidylcholine, but increased incorporation into phosphatidylethanolamine, phosphatidic acid, phosphatidylinositol and cardiolipin.
De Torrontegui & Berthet (1966) (1964) . Pooled adipose tissue (approx. 25g) from five to six rats was minced with scissors and placed in small plastic bottles. Each bottle, containing approx. 13g of tissue and 20ml of Krebs-Ringer-Tris buffer supplemented with 3% albumin and 1 mg of crude collagenase/ml, was incubated for 60min at 370C in an orbital shaker. Krebs-Ringer-Tris buffer of the following composition was used in all experiments: 120mm-NaCl; 1.4 mM-CaCl2; 5.2 mM-KCl; 1.4 mM-MgSO4; 5 mM-Tris. The buffer was prepared daily and adjusted to pH 7.4 at 370C, with NaOH, after addition of albumin powder. At the end of 60 min digestion, cells were filtered through one layer of nylon chiffon and washed twice with albumin buffer. Glycerol was analysed as previously described (Fain et al., 1973) . Fat-cells were counted with a light microscope as previously described (Malbon et al., 1978 In the studies shown in Tables 3-7 the phospholipids were separated by one-dimensional chromatography using only the first solvent system. This procedure was equally suitable for the separation of phosphatidylcholine, phosphatidylethanolamine and phosphatidylinositol. Phosphatidic acid could not be separated from phosphatidylserine, which resulted in a lower specific radioactivity for the phosphatidic acid area. However, since the uptake of radioactivity into phosphatidylserine is less than 6% of that into phosphatidic acid; the radioactivity in this spot is assumed to be phosphatidic acid. The uptake of [ 32PIP, into cardiolipin and sphingomyelin is only reported in Table 1 (White, 1973 Vol. 186 The incorporation of label into phosphatidylinositol was increased by low concentrations of adrenaline (1-3.3,pM). Higher concentration of adrenaline did not result in any further stimulation of phosphatidylinositol labelling. Phosphatidic acid labelling was only slightly stimulated by adrenaline (Fig. 1) . The specific radioactivity of phosphatidylcholine was not appreciably modified by adrenaline, whereas that of phosphatidylethanolamine was markedly decreased. An inverse relationship was observed between lipolysis and the specific radioactivity of phosphatidylethanolamine (Fig. 1) .
Adrenaline is both an a-and fl-adrenergic agonist.
To determine which actions of adrenaline were due to a-stimulation and which to f-activation, pure a-andf,-adrenergic agonists and antagonists were employed. The a-adrenergic blocking agent phentolamine did not affect significantly the incorporation of label into phospholipids or lipolysis due to adrenaline (Table 2) . However, the marked increase in phosphatidylinositol labelling produced by adrenaline was blocked by phentolamine. There was actually a decrease in the specific radioactivity of phosphatidylinositol and all other phospholipids in the presence of adrenaline plus phentolamine (Table 2) . Similar results were seen with isoproterenol, a f-adrenergic agonist, except that phosphatidylcholine was unaltered ( (Table 2 ). These results suggest that the increase in phosphatidylinositol labelling observed with adrenaline is an a-action. In support of this conclusion, the a-adrenergic agonist methoxamine also increased the specific radioactivity of phosphatidylinositol (Table 2) .
Characterization of the a-receptor involved in the phosphatidylinositol effect infat-cells. Considerable evidence indicates that a-receptors can be divided into at least two subclasses, i.e. al and a2 (Berthelsen & Pettinger, 1977; U'Prichard et al., 1978; Hoffman et al., 1979; Wood et al., 1979) . The use of selective agonists and antagonists have clarified this point. It has been shown that phentolamine is an a-adrenergic antagonist equipotent at al-and a2-receptors (Hoffman et al., 1979) , prazosin is 3-4 orders of magnitude more potent at al-than at a2-receptors (U'Prichard et al., 1978; Hoffman et al., 1979) and yohimbine has a 500-fold greater affinity for a2-than for al-receptors (Hoffman et al., 1979) . On the other hand, methoxamine is considered an a,-agonist, whereas clonidine is a2 (Berthelson & Pettinger, 1977) . The action of a-adrenolytic agents on the adrenaline-mediated increase in phosphatidylinositol labelling was tested (Table 3 ). Prazosin completely blocked the effect of adrenaline (10pM) at a concentration of 0.1 M, whereas l00,uM-yohimbine or 10#uM-phentolamine were required to produce the same inhibition. a-Adrenergic blockers did not modify either the basal incorporation of [32pIp, into phosphatidylinositol (Table 3) or adrenaline-induced lipolysis (results not shown). On the other hand, methoxamine produced a 2-fold increase in phosphatidylinositol labelling (Table 2) , whereas clonidine (1-1004uM) produced no effect on this parameter (results not shown). Effect of lipolytic agents on the incorporation of P1 into phospholipids and role of unesterified fatty acids
The effects of non-adrenergic lipolytic agents are shown in Table 4 . Both corticotropin and dibutyryl (Table 4 ). The effects of corticotropin and dibutyryl cyclic AMP were identical with those of isoproterenol ( Table 4 ).
The accumulation of unesterified fatty acids intracellularly can uncouple oxidative phosphorylation (Angel et al., 1971) . Since large amounts of cells were employed in these studies, it is possible that the unesterified fatty acids released by adipocytes in the presence of lipolytic agents may saturate the binding sites for unesterified fatty acids on (Table 5 ).
The effects of lipolytic agents on [(32p]p incorporation were restored if oleate was added to the medium (Table 5 ). Basal and hormone-stimulated lipolysis were higher if fewer cells were incubated in the medium with a higher concentration of albumin (compare Tables 2 and 4 with Table 5 ). The activation of lipolysis due to hormones, but not that due to dibutyryl cyclic AMP, was decreased by the addition of oleate (Table 5 ). Basal incorporation of ["32p]p into phospholipids was not significantly affected by increasing the concentration of albumin in the medium or adding unesterified fatty acids (Table 5 ).
Effect of propranolol on the incorporation of Pi into phospholipids
In an effort to clarify the action of propranolol on the incorporation of phosphate into phosphatidylinositol, the action of the optical isomers of propranolol was tested. The (+)-isomer does not block the lipolytic response due to adrenaline (Table 6 ). However, (+)-propranolol increased phosphatidylinositol labelling and this action was additive to that of adrenaline (Table 6 ). The (-)-isomer of propranolol produced the same effects as the racemic mixture on lipolysis and incorporation of [12PIP, into phosphatidylinositol (cf. Tables 2 and 6).
Effect of insulin, adenosine, and ionophore A23187 on the incorporation ofP1 into phospholipids Adenosine, phenylisopropyladenosine and carbamoylcholine did not modify the incorporation of Table 7 for cells incubated in Ca2+-free buffer containing 1 mM-EGTA. However, insulin increased slightly the labelling of all phospholipids in regular buffer (results not shown).
Role of Ca2+ in the labelling ofphospholipids with P The role of extracellular Ca2+ in the action of a-adrenergic agents, propranolol, insulin and ionophore A23187 on phospholipid labelling was tested by incubating the cells in medium with or without added Ca2+ in which 1 mM-EGTA was present. The specific radioactivity of phosphatidylinositol was lower in cells incubated in Ca2+-free buffer containing 1 mM-EGTA (the values for cells incubated in the absence of Ca2+ were 44, 72, and 82% of those in the presence of Ca2+ for the three experiments shown in Table 7 ). Incubation of fat-cells in the absence of Ca2+ and presence of 1mM-EGTA did not decrease but actually enhanced the increases due to insulin and ionophore A23187 of [32P]P1 incorporation into phosphatidylinositol ( Table 7) . Table 7 . The increases due to methoxamine or adrenaline in the presence of propranolol were unaffected by EGTA or EGTA plus Ca2+ (Table 7) .
Recently, Hirata et al. (1979) reported that /1-adrenergic agonists increase the methylation of phospholipids in rat reticulocyte 'ghosts'. The possibility that the decrease in the amount of labelled phosphatidylethanolamine might be due in part to its conversion into phosphatidylcholine was studied by incubating cells in medium containing L-[Me-3Hlmethionine. No increase in the incorporation of 3H was observed with fl-adrenergic amines. In fact, in two of the three experiments performed a small decrease was produced (results not shown). (Smith etal., 1979) . The a-adrenergic increase in phosphatidylinositol labelling was also observed in Ca2+-free medium containing EGTA; this indicates that it is independent of extracellular Ca2+. Lawrence & Larner (1978) reported that methoxamine was unable to inactivate adipocyte glycogen synthase in Ca2+-free medium containing EGTA. In addition, the cation ionophore A23187 mimicked this effect of methoxamine on glycogen synthase. Our data are consistent with the hypothesis that phosphatidylinositol metabolism plays an important role in Ca2+ gating (Michell, 1975; Berridge & Fain, 1979; Fain & Berridge, 1979) . Alternatively, catecholamine effects on Ca2+ gating and phosphatidylinositol metabolism may be independent. However, there is a close association between a-adrenergic regulation of phosphatidylinositol turnover and Ca2+ entry in many systems (Michell, 1975 (Michell, , 1979 Jones & Michell, 1978) . Stein & Hales (1974) found that insulin increased the incorporation of phosphate into rat fat-cell phospholipids, which was attributed to an increase in the specific radioactivity of ATP. The increase due to insulin in the labelling of all phospholipids in regular buffer could be due to changes in the specific radioactivity of ATP, as already shown by Stein & Hales (1974) . However, the increases in phosphatidylinositol labelling due to a-adrenergic catecholamines are apparently unrelated to changes in the specific radioactivity of ATP, since similar increases were not seen in labelling of other phospholipids. The same argument applies to the inhibition of [32p1pl incorporation into certain phospholipids by agents that activate lipolysis including /J-catecholamines. The only way to explain the effects of either a-or f-catecholamines on phospholipid labelling through changes in the specific radioactivity of ATP is to postulate separate ATP pools involved in the synthesis of each phospholipid.
In medium containing 1 mM-EGTA plus 2.5 mMCa2+ insulin did not increase the labelling of phosphatidylinositol. However, we observed that under these conditions the ability of insulin to stimulate [1-14C]glucose oxidation and inhibit lipolysis was unaltered (results not shown). The explanation for these results is not apparent, but does indicate that the effects of a-adrenergic agonists on phosphatidylinositol labelling occur by mechanisms separate from those involved in any effect of insulin or ionophore A23 187 on phospholipid labelling.
The action of propranolol on phosphatidylinositol labelling seems to be independent of its ability to block fJ-adrenergic receptors since the (+)-isomer that is inactive in this respect produced nearly the same action as the active isomer on phosphatidylinositol labelling. This effect is independent of the presence of Ca2+ in the medium and is probably related to its local-anaesthetic properties. In fact local anaesthetics and propranolol enhanced the incorporation of labelled phosphate into phosphatidylinositol and phosphatidic acid in rat pineal glands (Eichberg et al., 1978) . These lipid-soluble cationic drugs exert their effects on phospholipid metabolism by redirection of synthesis towards phosphatidylinositol probably owing to inhibition of phosphatidate phosphohydrolase (Allan & Michell, 1975; Brindley & Bowley, 1975; Eichberg etal., 1978) .
The ability of lipolytic agents to decrease the labelling of all phospholipids may be related to an intracellular accumulation of unesterified fatty acids, since it was prevented by increasing the concentration of albumin in the medium and the presence of medium to which fatty acids were added restored it. The ability of adrenaline to decrease the incorporation of [ "2pIp1 into phosphatidylethanolamine was not observed in the presence of (+)-propranolol. No clear explanation exists to this finding, but it may be related to the local-anaesthetic properties of this compound. Stein & Hales (1972) reported that adrenaline markedly increased the incorporation of I 32p]p1 into phosphatidylcholine and this effect was blocked by propranolol. Stein (1975 Stein ( , 1977 subsequently reported that adrenaline had no effect on the specific radioactivity of ATP, markedly decreased ATP content and increased the incorporation of [32P1P into CDP-choline, but not into CDP-ethanolamine.
The decrease in ATP due to adrenaline in the experiments of Stein (1975 Stein ( , 1977 and Stein & Hales (1972) may have activated cholinephosphotransferase, which is known to be activated in liver by a decrease in ATP (Sribney et al., 1976 (Table 5 ). This suggests that the formation of this phospholipid is not regulated by the same factors that affect the other phospholipids.
